Nuformix team up with Oxilio to accelerate NXP001 oncology asset development No knee jerk reaction from Nuformix over CEO resignation Nuformix: Continue developing pipeline of repurposed drug assets Proactive - Nuformix poised to deliver pipeline assets with new cash and new chairman Traders Cafe with Zak Mir: Dr Anne Brindley, CEO Nuformix Nuformix's Dr Anne Brindley presents plans after conditional raise of just under £1.6mln Nuformix's Dr Anne Brindley plans to use extensive experience in industry to drive company forward
